ATE109142T1 - 1-(pyridinylamino)-2-pyrrolidinone, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. - Google Patents

1-(pyridinylamino)-2-pyrrolidinone, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.

Info

Publication number
ATE109142T1
ATE109142T1 AT90114659T AT90114659T ATE109142T1 AT E109142 T1 ATE109142 T1 AT E109142T1 AT 90114659 T AT90114659 T AT 90114659T AT 90114659 T AT90114659 T AT 90114659T AT E109142 T1 ATE109142 T1 AT E109142T1
Authority
AT
Austria
Prior art keywords
pyridinylamino
loweralkyl
pyrrolidinone
production
medicinal product
Prior art date
Application number
AT90114659T
Other languages
English (en)
Inventor
Richard Charles Dr Effland
David Gordon Dr Wettlaufer
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of ATE109142T1 publication Critical patent/ATE109142T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90114659T 1989-08-02 1990-07-31 1-(pyridinylamino)-2-pyrrolidinone, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. ATE109142T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/388,413 US4994472A (en) 1989-08-02 1989-08-02 1-(pyridinylamino)-2-pyrrolidinones as pain relievers

Publications (1)

Publication Number Publication Date
ATE109142T1 true ATE109142T1 (de) 1994-08-15

Family

ID=23534027

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90114659T ATE109142T1 (de) 1989-08-02 1990-07-31 1-(pyridinylamino)-2-pyrrolidinone, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.

Country Status (17)

Country Link
US (1) US4994472A (de)
EP (1) EP0413191B1 (de)
JP (1) JPH0674264B2 (de)
KR (1) KR0164437B1 (de)
AT (1) ATE109142T1 (de)
AU (1) AU635051B2 (de)
CA (1) CA2022484C (de)
DE (1) DE69011013T2 (de)
DK (1) DK0413191T3 (de)
ES (1) ES2059929T3 (de)
FI (1) FI903818A0 (de)
IE (1) IE65117B1 (de)
IL (1) IL95250A (de)
NO (1) NO903388L (de)
NZ (1) NZ234724A (de)
PT (1) PT94878B (de)
ZA (1) ZA906049B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356908A (en) * 1989-04-21 1994-10-18 E. I. Du Pont De Nemours And Company Fungicidal oxazolidinones
EP0435843B1 (de) * 1989-12-27 1994-06-15 Monsanto Company Substituierte Pyridin-Verbindungen
AUPM656594A0 (en) * 1994-06-30 1994-07-21 Orbital Engine Company (Australia) Proprietary Limited A method and apparatus relating to control of the operation of an internal combustion engine
CA2252039C (en) * 1996-04-12 2002-12-24 Hoechst Marion Roussel, Inc. Isatin derivatives as acetylcholinesterase inhibitors and analgesics
US6100276A (en) * 1996-04-12 2000-08-08 Aventis Pharmaceuticals Inc. Isatin derivatives as acetylcholinesterase inhibitors and analgesics
US20050065205A1 (en) 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
AU2003281214A1 (en) * 2002-07-02 2004-01-23 Blanchette Rockefeller Neurosciences Institute PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPAlpha SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS
TW201207390A (en) 2004-05-18 2012-02-16 Brni Neurosciences Inst Method for screening agent for antidepressant activity
GB0412019D0 (en) * 2004-05-28 2004-06-30 Novartis Ag Organic compounds
CA2617003A1 (en) 2005-07-29 2007-02-08 Blanchette Rockefeller Neurosciences Institute Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory
CA2674773A1 (en) 2007-02-09 2008-08-21 Blanchette Rockefeller Neurosciences Institute Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670184A1 (de) * 1967-01-20 1971-01-21 Boehringer Sohn Ingelheim Verfahren zur Herstellung heterocyclisch substituierter Hydrazino-imidazoline-(2)
US4260767A (en) * 1979-12-26 1981-04-07 American Cyanamid Company 2-Pyridylhydrazides
US4324884A (en) * 1980-09-25 1982-04-13 General Electric Company Organic amine catalyzed method for making polyetherimide
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
JPH0699307B2 (ja) * 1987-08-20 1994-12-07 キッセイ薬品工業株式会社 抗痴呆剤
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines

Also Published As

Publication number Publication date
NO903388L (no) 1991-02-04
NO903388D0 (no) 1990-08-01
CA2022484C (en) 2000-10-17
DK0413191T3 (da) 1994-10-24
NZ234724A (en) 1992-01-29
JPH0674264B2 (ja) 1994-09-21
DE69011013T2 (de) 1994-12-22
PT94878A (pt) 1991-04-18
ZA906049B (en) 1991-04-24
AU6000290A (en) 1991-02-07
EP0413191B1 (de) 1994-07-27
PT94878B (pt) 1997-08-29
KR0164437B1 (ko) 1999-01-15
EP0413191A1 (de) 1991-02-20
KR910004597A (ko) 1991-03-29
US4994472A (en) 1991-02-19
DE69011013D1 (de) 1994-09-01
IL95250A (en) 1994-01-25
IE902786A1 (en) 1991-02-27
FI903818A0 (fi) 1990-07-31
JPH0368572A (ja) 1991-03-25
ES2059929T3 (es) 1994-11-16
IL95250A0 (en) 1991-06-10
IE65117B1 (en) 1995-10-04
CA2022484A1 (en) 1991-02-03
AU635051B2 (en) 1993-03-11

Similar Documents

Publication Publication Date Title
ATE163012T1 (de) N-substituierte 4-pyrimidinamine und - pyrimidindiamine, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel
DE69016530D1 (de) 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
ATE109142T1 (de) 1-(pyridinylamino)-2-pyrrolidinone, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
ATE118002T1 (de) 2,3-dihydro-1-(pyridinylamino)-indole, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time